The Consumer Financial Protection Bureau (CFPB) has proposed a rule to define a market for general-use digital consumer payment applications. Larger participants in this market would be subject to CFPB supervision and examination authority under the Consumer Financial Protection Act (CFPA). The proposed market would cover providers of funds transfer and wallet functions through consumer […]
Read more
Through government contracts, advertising agencies can help state, local, and federal governments communicate their mission and important messages to the general public to inspire behavioral change, accelerate adoption of vital programs, and contribute to the greater good. To help agencies navigate the perceived complexities of the government contracting process, the 4A’s Government Relations team has […]
Read more Aug. 30, 2022 – When members of the House and Senate return to Washington Sept. 6 following the Labor Day holiday, they face competing priorities and tight timeframes to take action on the federal budget and user fees, which expire on Sept. 30. Failure to pass the fiscal year 2023 (FY 2023) budget and reauthorize […]
Read more
May 2, 2022 – Although Medicare Advantage (MA) plans often are touted for delivering more benefits at a lower cost than traditional Medicare, some critics argue that MA organizations (MAOs) deny beneficiaries coverage that they would receive under Medicare rules – including MRIs and post-acute care – in order to increase profits. As MA plan […]
Read more
April 4, 2022 – The fiscal year (FY) 2023 budget proposed by President Joe Biden last week emphasizes fiscal restraint more than new, big spending programs, but it does ask for increased funding for pandemic preparedness, the Food and Drug Administration (FDA), and projects such as the Cancer Moonshot and the Advanced Research Projects Agency […]
Read more
Feb. 15, 2022 – Dr. Robert Califf was confirmed to be the next Commissioner of Food and Drugs in a close 50-46 Senate vote today. In a sign of the times, during the 2016 vote for Califf’s first stint as FDA Commissioner, he was confirmed 89-4. “We expect Califf to be a strong leader for […]
Read more Feb. 7, 2022 – Although the nomination of Dr. Robert Califf to return as FDA Commissioner was advanced by the Senate House, Education, Labor, and Pensions (HELP) Committee just weeks ago and it appeared Califf was poised to be confirmed by the full Senate, new opposition to his nomination reportedly has switched at least some […]
Read more Dec. 20, 2021 — Dr. Robert Califf, President Joe Biden’s nominee for the FDA Commissioner position, spent roughly two hours answering questions volleyed his way during last week’s Senate Health, Education, Labor, and Pensions (HELP) Committee’s hearing on his nomination. Califf’s answers, peppered with details, facts and figures, references to senators’ home-state concerns, anecdotes about […]
Read more Nov. 15, 2021 – Many in the healthcare space are breathing a sigh of relief that President Joe Biden finally announced his nominee to be the new FDA Commissioner on Nov. 12: former FDA Commissioner Robert Califf, M.D. Although Coalition for Healthcare Communication Executive Director Jon Bigelow believes Califf will win Senate confirmation for a […]
Read more
Nov. 4, 2021 – Update on spending bill from Coalition for Healthcare Communication Executive Director Jon Bigelow: On Oct. 28, President Joe Biden announced a new “framework” for the Build Back Better Act, reducing the scope to $1.8 trillion and dropping several initiatives, conspicuously including measures to limit the cost of prescription drugs. Very quickly, […]
Read more